Category: Joint ventures/collaborations
-
Company Started for Gene Editing Rare Inherited Diseases
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells.
-
Peptide Discovery Company to Gain $3.3B in Licensing Deals
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion.
-
New Company Creating High-Capacity Gene Therapies to the Brain
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders.
-
Bone Regeneration Experiment Begun on Space Station
An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station.
-
Venture Investor to Back Semiconductor Start-Ups
A technology investment company is partnering with a Silicon Valley incubator program to support start-up businesses developing new types of semiconductors.
-
FDA Clears AI Heart Failure Detection System
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure.
-
Trial Begins Testing Digital Therapy for Anxiety with Lung Disease
A clinical trial is underway testing a mobile app designed to help people with a serious lung disorder manage anxiety that often accompanies the disease.
-
Grant Funds Implanted Brain-Computer Spinal Injury Device
A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award.
-
Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.